EXPERIENCE OF A MINIMALLY-INVASIVE STAGE TREATMENT OF MULTIPLE  ABSCESSES OF LIVER

Relevance. Liver abscesses remain one of the most urgent problems in abdominal surgery, reaching 2-3 cases per 100,000 people. A wide range of causes, the complexity of diagnosis and the imperfection of treatment methods reaching a high mortality, from 2 to 31% according to different authors. The abscesses developing as a complication in the postoperative period are the greatest difficulty in diagnosis and treatment. The advantage of minimally invasive technologies at the present stage of development of surgery is indisputable. However, the question remains of the indications for their use, phasing and technology of implementation. Purpose of the study. On the clinical example, to show the possibility, logic and sequence of minimally invasive treatment in a patient with multiple liver abscesses. Materials and methods. Presented a clinical case of minimally invasive treatment of postoperative complications in a patient receiving primary treatment for multiple primary cancer - cholangiocarcinoma and kidney cancer with the development of multiple liver abscesses of the ambiguous nature (cholangiogenic, pyogenic, traumatic, ischemic). Result. In the presented clinical case are presented the possibilities of a staged, minimally invasive treatment of multiple liver abscesses

Download Full-text

Staged surgical treatment of the patient with chronic pancreatitis

Annaly khirurgicheskoy gepatologii = Annals of HPB surgery ◽

10.16931/1995-5464.2021-3-149-155 ◽

2021 ◽

Vol 26 (3) ◽

pp. 149-155

Author(s):

N. Yu. Kokhanenko ◽

A. V. Glebova ◽

O. G. Vavilova ◽

A. A. Kashintsev ◽

S. A. Kaliuzhnyi ◽

...

Keyword(s):

Chronic Pancreatitis ◽

Surgical Treatment ◽

Minimally Invasive ◽

Clinical Case ◽

Minimally Invasive Treatment ◽

Gastric Fistula ◽

Invasive Treatment ◽

Head Of The Pancreas ◽

Staged Treatment

A clinical case of successful surgical treatment of a patient with chronic pancreatitis, complicated by suppuration of a postnecrotic cyst and the formation of a cysto-gastric fistula. As a result of the conservative and minimally invasive treatment, the pseudocyst was drained, and the cystogastric fistula was closed. The staged treatment was completed by resection of the head of the pancreas with the formation of an anastomosis.

Download Full-text

Treatment of hypertrophic scars and keloids using an intralesional 1470 nm bare-fibre diode laser: a novel efficient minimally-invasive technique

Scientific Reports ◽

10.1038/s41598-020-78738-9 ◽

2020 ◽

Vol 10 (1) ◽

Author(s):

Ke Li ◽

Fabio Nicoli ◽

Chunxiao Cui ◽

Wen Jing Xi ◽

Ahmed Al-Mousawi ◽

...

Keyword(s):

Minimally Invasive ◽

Diode Laser ◽

Minimally Invasive Treatment ◽

Treatment Modalities ◽

Invasive Technique ◽

Hypertrophic Scars ◽

Invasive Treatment ◽

Keloid Scars ◽

Wide Range ◽

Bare Fibre

AbstractHypertrophic and keloid scars result from abnormal wound healing and can have a variable response to a number of available treatment modalities. The evolution of laser treatments in recent years has shown a wide range of clinical applications including their use in the treatment of scars. We investigated the effectiveness of a 1470 nm diode laser using an intralesional optical fibre delivery device in the treatment of hypertrophic and keloid scars. We evaluated its safety and efficacy as a novel and minimally invasive treatment alternative for scar modulation and volume reduction. A prospective cohort study was performed involving 21 patients with hypertrophic scars (HS) (n = 9) and keloids (n = 12) resulting from various aetiology. Patients were treated with one to three treatment sessions. Comprehensive evaluations were performed using the Vancouver Scar Scale, Doppler ultrasound, Cutometer, Mexameter and PeriCam PSI. Scar thickness was reduced by an average of 0.308 ± 0.138 cm (p < 0.001). In particular the two subgroups showed a significant 27.7% and 28.2% reduction in scar thickness of HS and Keloids, respectively. Scar firmness showed a significant improvement of 1.2% (p < 0.05) for HS, though for keloids this was 0.4% (p = 0.26). Keloids had a significant reduction in pigmentation at 21.3%. Blood perfusion had a significant reduction of 29.6% in HS and 22.7% in Keloids. Overall VSS total score improvement of 42% in the HS and at 37.9% in the Keloid subgroup. No adverse events such as hypo/hyperpigmentation, skin infection, or recurrence were reported. This study shows that the intralesional 1470 nm bare-fibre diode laser significantly improved hypertrophic and keloid scars based on both subjective and objective analyses and supports this type of laser therapy as a safe and effective minimally-invasive treatment option.

Download Full-text

Percutaneous Minimally Invasive Treatment for the Trigeminal Neuralgia: A Review

Journal of Anesthesia and Perioperative Medicine ◽

10.24015/japm.2015.0023 ◽

2015 ◽

Vol 2 (3) ◽

pp. 167-174

Author(s):

Xiang-Fei Guo ◽

Jun Ma

Keyword(s):

Trigeminal Neuralgia ◽

Minimally Invasive ◽

Minimally Invasive Treatment ◽

Invasive Treatment

Download Full-text

EAU, AUA and NICE Guidelines on Surgical and Minimally Invasive Treatment of Benign Prostate Hyperplasia: A Critical Appraisal of the Guidelines Using the AGREE-II Tool

Urologia Internationalis ◽

10.1159/000517675 ◽

2021 ◽

pp. 1-10

Author(s):

Dmitry Enikeev ◽

Vincent Misrai ◽

Enrique Rijo ◽

Roman Sukhanov ◽

Denis Chinenov ◽

...

Keyword(s):

Minimally Invasive ◽

Treatment Options ◽

Stakeholder Involvement ◽

Minimally Invasive Treatment ◽

Invasive Treatment ◽

Agree Ii ◽

Prostate Hyperplasia ◽

Assessment Score ◽

Nice Guideline ◽

Agree Ii Tool

Objective: To critically appraise the methodological rigour of the clinical practice guidelines (CPGs) vis-à-vis BPH surgery as used by specialist research associations in the US, Europe and UK, and to compare whether the guidelines cover all or only some of the available treatments. Methods: The current guidelines issued by the EUA, AUA and NICE associations have been analyzed by 4 appraisers using the AGREE-II instrument. We also compared the recommendations given in the guidelines for surgical and minimally invasive treatment to find out which of these CPGs include most of the available treatment options. Results: According to the AGREE II tool, the median scores of domains were: domain 1 scope and purpose 66.7%, domain 2 stakeholder involvement 50.0%, domain 3 rigor of development 65.1%, domain 4 clarity of presentation 80.6%, domain 5 applicability 33.3%, domain 6 editorial independence 72.9%. The overall assessment according to AGREE II is 83.3%. The NICE guideline scored highest on 5 out of 6 domains and the highest overall assessment score (91.6%). The EAU guideline scored lowest on 4 out of 6 domains and has the lowest overall assessment score (79.1%). Conclusions: The analyzed CPGs comprehensively highlight the minimally invasive and surgical treatment options for BPH. According to the AGREE II tool, the domains for clarity of presentation and editorial independence received the highest scores. The stakeholder involvement and applicability domains were ranked as the lowest. Improving the CPG in these domains may help to improve the clinical utility and applicability of CPGs.

Download Full-text